Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00064844 · ClinicalTrials.gov registry record · Phase 4
Combination Nicotine Replacement for Alcoholic Smokers
A Phase 4 study, sponsored by Yale University.
- Completed
- Registry status
- Phase 4
- Development phase
- 96
- Enrollment target
NCT00064844 is a Phase 4 study that has completed, run by Yale University. The registered enrollment target is 96 participants.
The verdict
NCT00064844, a Phase 4 study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 96 participants
- Enrollment target
Study Summary
The overall objective of the study is to develop recommendations for treatment programs to help alcoholic smokers to stop smoking. A sample of 175 alcohol dependent cigarette smokers will be recruited from the community and treated in a 6-month outpatient alcohol and tobacco treatment program. The 175 patients will be divided into two groups. One group will receive an active nicotine patch and active nicotine gum. The other group will receive an active nicotine patch and placebo nicotine gum. Followup assessments will be conducted for 1-year from the beginning of treatment.
Interventions
- DRUG Nicoderm CQ nicotine patch
- BEHAVIORAL Cognitive Behavior Therapy for alcohol and smoking cessation
- DRUG Placebo gum
- DRUG Nicotine gum - Nicorette®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2002-08 |
| Est. Completion | 2006-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00064844
The ClinicalTrials.gov registry entry for NCT00064844 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 96 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Nicoderm CQ nicotine patch is the first listed.
NCT00064844 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00064844 about?
NCT00064844 is a clinical study titled "Combination Nicotine Replacement for Alcoholic Smokers". The overall objective of the study is to develop recommendations for treatment programs to help alcoholic smokers to stop smoking. A sample of 175 alcohol dependent cigarette smokers will be recruited from the community and treated in a 6-month outpatient alcohol and tobacco treatment program. The 1...
What is the current status of trial NCT00064844?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 96 participants. The study started on 2002-08. Estimated completion is 2006-07.
What interventions are being tested in trial NCT00064844?
The interventions under investigation include: Nicoderm CQ nicotine patch (DRUG), Cognitive Behavior Therapy for alcohol and smoking cessation (BEHAVIORAL), Placebo gum (DRUG), Nicotine gum - Nicorette® (DRUG).
Who is sponsoring clinical trial NCT00064844?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.